Introduction
According to the “2020 Global Cancer Report” recently released by the World Health Organization’s International Agency for Research on Cancer (IARC), the top ten new cancer cases in China in 2020 are as follows: lung, colorectal, gastric, breast, liver, esophageal, thyroid, pancreatic, prostate, and cervical cancers (WHO/IARC published the World Cancer Report 2020). Most of the cases are gastrointestinal cancers, which are closely linked to individuals with high sugar and low fiber diet, helicobacter pylori infection, sedentary, obesity, drinking, and smoking (
1–
5). They are generally diagnosed at an advanced stage, which seriously impacts the prognosis and life quality of patients. In order to reduce the incidence and mortality of gastrointestinal cancers, as well as improve the survival rate of patients, it is critical to excogitate the treatment and diagnosis of gastrointestinal cancers
. In recent years, noble metal nanoparticles have received significant attention in cancer medical research due to their unique efficacy and specificity in imaging, diagnosis, and therapy (6–8). Gold nanoparticles (GNPs) are widely used, particularly in cancer research, because of their ease of synthesis, adjustable size and shape, remarkable biocompatibility, unique optical properties, and surface plasmon resonance (SPR) properties (9–11). Different GNPs have been designed for different types of cancers. The expression of surface receptors, and tumor environment are utilized for photothermal therapy (
12), immunotherapy (
13), photodynamic therapy (
14), gene therapy (
15), targeted therapy (
16), and a combination of multiple treatments (
15), allowing the integration of cancer diagnosis and treatment. This review focuses on the application of GNPs in gastrointestinal cancer.